DalsnaFinance › Analyst accuracy › All targets
Every price target we have verified from published news, newest first: 134 targets from Morgan Stanley. Each one shows the article it came from and links to its full entry, and is judged on the close on the date it comes due. “At” is the closing price nearest the day the target was reported, the price we score it from; it is not an earlier target.
Showing targets from Morgan Stanley only. All targets Morgan Stanley’s record →
with a $235 price target about 20% below where the stock had been trading.
The brokerage lifted its target to $410 from $394 while retaining an "Overweight" rating and naming the company its top pick.
lowered its price target to $5.30 from $7.70
ACN Maintained by Morgan Stanley -- Price Target Raised to $175
lowering its price target to $5.20 from $8.00
Morgan Stanley raised its price target on the lodging services provider to $25 from $22
In his research note, Feather also lowered his price target on PTON to $4.50,
Morgan Stanley upgraded M&T Bank (NYSE:MTB) to Overweight from Equalweight on Monday, raising its price target to $304 from $253.
Morgan Stanley upgraded Synopsys (NASDAQ:SNPS) to Overweight from Equalweight on Tuesday and set a price target of $500.00.
raised his price target on the cloud data company to $470 from $300.
Morgan Stanley reiterated an Overweight rating on Navan Inc
to $83 from $93 while maintaining an Underweight rating
Morgan Stanley raised its price target on Oracle Corp. shares to $210 from $207 while maintaining an Equalweight rating
raised its price target for the stock to $150 from $124, implying 43% upside
Morgan Stanley reiterated an Overweight stock rating on BioMarin Pharmaceutical Inc. with a price target of $124.00, following a settlement agreement with Ascendis.
raising its price target to $238 from $227, maintaining its Overweight rating.
Morgan Stanley cut its SoFi Technologies price target to $15 from $16, signaling tempered expectations.
Remain Equal-weight; PT to $23
Morgan Stanley downgraded VTEX (NYSE:VTEX) to Equalweight from Overweight and lowered its price target to $4.00 from $4.50.
Morgan Stanley raised its price target on Marvell Technology Inc. (NASDAQ:MRVL) to $246.00 from $224.00 while maintaining an Equalweight rating.
Morgan Stanley reiterated an Equalweight rating and $14.00 price target on Ford Motor (NYSE:F) following the company's announcement of a new president for its energy division.
Morgan Stanley upgraded Dynatrace Inc to Overweight from Equal-weight on Tuesday, saying improving demand for observability software, a large customer renewal cycle and stronger artificial intelligence capabilities could drive a sustained acceleration in growth.
Morgan Stanley reiterated an Overweight rating on Kanzhun Ltd. (NASDAQ:BZ) shares with a $24.00 price target.
MRK Upgraded by Morgan Stanley -- Price Target Raised to $179
Morgan Stanley resumed coverage on Keurig Dr Pepper Inc. (NASDAQ:KDP) with an Overweight rating and set a price target of $38.00.
Morgan Stanley raised its price target on Moderna Inc. shares to $89 from $39 while maintaining an Equalweight rating on the stock.
Analyst Kristine Liwag "maintained her $205 price target, indicating potential upside of nearly 35% from its previous close."
CVX Maintained by Morgan Stanley -- Price Target Raised to $218
Morgan Stanley lowered its price target on WeRide Inc (NASDAQ:WRD) to $12.00 from $13.10 while maintaining an Overweight rating on the stock.
Morgan Stanley upgraded Honeywell Aerospace Inc (NASDAQ:HONA) from Equalweight to Overweight with a price target of $205.00.
Morgan Stanley initiates Target Hospitality stock at overweight
Morgan Stanley lifted their price target on Marathon Digital from $5.50 to $6.00
Morgan Stanley raised its Riot Platforms (NASDAQ: RIOT) price target to $43 from $36 on Thursday, following Riot's 191 MW critical IT lease at Rockdale.
Morgan Stanley raised its price target on Cisco Systems to $135 from $130 while maintaining an Overweight rating.
Morgan Stanley initiated coverage on Achieve Life Sciences with an overweight rating and a price target of $13.00.
Morgan Stanley raised its price target on Lumentum Holdings Inc. to $1,000 from $900 while maintaining an Equalweight rating.
The investment bank set a $69 price target on HPE.
Morgan Stanley downgrades Global-E Online stock rating on valuation
Morgan Stanley upgraded Lincoln Electric to Equalweight from Underweight and raised its price target to $283 from $257.
Morgan Stanley initiates Csquare stock with overweight rating on retail colocation exposure
Morgan Stanley raised its price target on JFrog Ltd. (NASDAQ:FROG) to $100 from $95 while maintaining an Equalweight rating
Morgan Stanley lowered its price target on HubSpot Inc (NYSE:HUBS) to $287 from $350 while maintaining an Overweight rating on the shares.
Morgan Stanley raises AMD stock price target to $465 on earnings outlook
Morgan Stanley upgraded Humana ([NYSE:HUM](https://www.investing.com/equities/humana-inc)) from Underweight to Equalweight and raised its price target to $370.00 from $249.00.
Morgan Stanley downgraded Circle Internet to underweight from equal-weight on Monday and cut its price target to $38 from $106
Morgan Stanley raised its price target to $14 from $13 in a note published Friday, crediting stronger-than-expected R2 demand while keeping its underweight rating intact.
Morgan Stanley reiterated an Overweight rating and $335.00 price target on Amazon.com (NASDAQ:AMZN) stock.
Terence Flynn, a Morgan Stanley (NYSE: MS) analyst, recently raised his CRISPR Therapeutics price target to $60, up from $33, and upgraded his rating to 'hold.'
James Faucette's upwardly revised price target of $51 still signals potential for significant downside from its previous close.
Morgan Stanley reaffirmed its 'Overweight' rating on Akamai (AKAM) in a July 27 research note shared with me, keeping its price target at $165
Retracted targets, ones we found we had misreported, are not listed here and count toward nothing; each firm's row on the analyst accuracy page lists its own under "Retracted". These are facts about what each firm published, not recommendations from Dalsna Finance.
Full methodology: how targets are collected, scored, ranked and corrected, what each field means, and how to cite the data.